Intravenous. 1 Paclitaxel 135 mg/m 2 by iv. infusion over 3 h Cisplatin 60 mg/m 2 iv. infusion over 3 h 15 Paclitaxel 135 mg/m 2 by iv. infusion over 3 h Etoposide 150 mg/m 2 iv. infusion over 1 h ...
The infusion rate should be reduced by 50% in ... Thus far, the combination of cetuximab and radiation has never been compared with cisplatin-based chemoradiation, which is still considered ...
with chemotherapy (cisplatin/carboplatin and pemetrexed). BAY 2927088, which combines inhibition of HER2 (including exon 20 insertions and point mutations) with blockade of EGFR, both mutations ...
Additionally, we conducted sensitivity analyses to explore the impact of time-of-day infusion on survival outcomes, focusing on populations with ≥2 ICI infusions at cut-off times of 15:30 and 16:00.
Cisplatin, a widely used anticancer drug, has been used in combination therapies but its use is limited by severe side effects, including renal toxicity, highlighting the need for safer and more ...
Peroxynitrite induces cell death, and can influence signal-transduction processes, mitochondrial function and signalling of apoptosis. The formation and reactions of peroxynitrite play a ...
Stomach cancer, also known as gastric cancer, begins in the cells that line the stomach. The vast majority of stomach cancers are the adenocarcinoma type, which affects the glandular mucus ...
Regional citrate anticoagulation was used in all patients underwent CRRT. Monitor both Total Calcium (Total Ca) and ionized Calcium (iCa) levels before and after the filter, and adjust the rate of ...